TF and breast carcinoma: Inhibition of the galectin–TF interaction by anti-TF antibody, anti-galectin-3 antibody, modified citrus pectin, or lactulosyl-l-leucine suppressed the adhesion of human breast carcinoma cells to HUVECs and endothelial bone marrow cells 60 (HBMECs-60) in vitro and in ex vivo perfused porcine dura mater model (48).